Pharma & Biotech

Nuvalent Inc. reported a second-quarter GAAP loss per share of $1.39, a figure that fell outside the range of analyst...

Investors in Denali Therapeutics are facing a period of intense volatility as the biotech firm approaches a critical regulatory milestone....

Assembly Biosciences finds itself at a critical juncture, with its stock caught between compelling long-term potential and immediate selling pressure....

How does a clinical-stage biotechnology firm justify burning through nearly a quarter of a billion dollars in a single quarter?...

New clinical evidence has positioned Novo Nordisk's weight management medication Wegovy for a potential market resurgence. Recent findings demonstrate the...

Centene Corporation’s stock continues to face headwinds as a critical September 8 deadline approaches for investors seeking lead plaintiff status...

Pharmaceutical giant Eli Lilly finds itself navigating a complex pricing landscape as new regulatory measures from the Trump administration compel...

While numerous healthcare sector stocks continue grappling with pandemic aftershocks and broader economic headwinds, medical technology giant Becton Dickinson is...

The coming weeks represent a pivotal period for clinical-stage biotech company AnaptysBio, whose immunology-focused pipeline faces a significant test. With...

The biopharmaceutical company Liquidia Corporation has captured significant analyst attention following the remarkably successful commercial launch of its flagship pulmonary...